At a glance
- Originator Academy of Sciences of the Czech Republic; Nonindustrial source
- Developer Gilead Sciences; Nonindustrial source
- Class Antineoplastics; Antivirals; Nucleotides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections; Human papillomavirus infections; Polyomavirus infections; Solid tumours
Most Recent Events
- 13 Jun 2005 Preclinical trials in Solid tumours in USA (unspecified route)
- 13 Jun 2005 Data presented at the 18th International Conference on Antiviral Research (ICAR-2005) have been added to the Cancer pharmacodynamics section
- 25 Jul 2001 This compound is still in active development as a potential anticancer agent